Inventor · disambiguated record
Thomas Fuchss
Also filed as: FUCHSS THOMAS
25 granted patents·10 pending applications·62 citations·filing 2001–2025
94Inventor score
Files withMERCK PATENT GMBH19ALTANA PHARMA AG7FUCHSS THOMAS4MERCK PATENT GES MIT BESCHRANKTER HAFTUNG2NYCOMED GMBH2
Top patents by PatentIndex Score
35 records- 0193US9126952B2MorpholinylquinazolinesMEDERSKI WERNER·Filed 2011·Granted Sep 8, 2015·19 cites·7 claims
- 0286US11065253B2ArylquinazolinesMERCK PATENT GMBH·Filed 2019·Granted Jul 20, 2021·1 cites·7 claims
- 0386US10172859B2ArylquinazolinesMERCK PATENT GMBH·Filed 2017·Granted Jan 8, 2019·4 cites·14 claims
- 0485US9000153B2Imidazo[4,5-c]quinolines as DNA-PK inhibitorsFUCHSS THOMAS·Filed 2011·Granted Apr 7, 2015·9 cites·12 claims
- 0584US10457677B2Imidazolonylquinolines and the use thereof as ATM kinase inhibitorsMERCK PATENT GMBH·Filed 2016·Granted Oct 29, 2019·3 cites·43 claims
- 0684US9598408B2Imidazo[4,5-C]quinolines as DNA-PK inhibitorsMERCK PATENT GES MIT BESCHRANKTER HAFTUNG·Filed 2015·Granted Mar 21, 2017·5 cites·3 claims
- 0782US9732094B2ArylquinazolinesMERCK PATENT GMBH·Filed 2014·Granted Aug 15, 2017·4 cites·3 claims
- 0881US8546613B2SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomasFUCHSS THOMAS·Filed 2009·Granted Oct 1, 2013·6 cites·6 claims
- 0981US2023203034A1Imidazolonylquinolines and the use thereof as atm kinase inhibitorsMERCK PATENT GMBH·Filed 2023·Application pending·0 cites
- 1078US9670142B21,3-diaminocyclopentane carboxamide derivativesMERCK PATENT GMBH·Filed 2014·Granted Jun 6, 2017·4 cites·18 claims
- 1177US11053233B2Solid form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanolMERCK PATENT GMBH·Filed 2018·Granted Jul 6, 2021·1 cites·16 claims
- 1275US11103512B2Crystalline form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanolMERCK PATENT GMBH·Filed 2018·Granted Aug 31, 2021·1 cites·19 claims
- 1373US11608338B2Imidazolonylquinolines and the use thereof as ATM kinase inhibitorsMERCK PATENT GMBH·Filed 2021·Granted Mar 21, 2023·0 cites·8 claims
- 1471US10975075B2Imidazolonylquinolines and the use thereof as ATM kinase inhibitorsMERCK PATENT GMBH·Filed 2020·Granted Apr 13, 2021·0 cites·20 claims
- 1568US10745399B2Imidazolonylquinolines and the use thereof as ATM kinase inhibitorsMERCK PATENT GMBH·Filed 2019·Granted Aug 18, 2020·0 cites·21 claims
- 1668US7317021B2Aminopyridine-derivatives as inductible no-synthase inhibitorsALTANA PHARMA AG·Filed 2004·Granted Jan 8, 2008·3 cites·11 claims
- 1764US6716990B2Process and intermediates for the preparation of imidazopyridinesALTANA PHARMA AG·Filed 2001·Granted Apr 6, 2004·2 cites·2 claims
- 1863US2025188080A1Imidazolonylquinoline compounds and therapeutic uses thereofMERCK PATENT GMBH·Filed 2025·Application pending·0 cites
- 1960US7781453B2Aminopyridine-derivativesALTANA PHARMA AG·Filed 2007·Granted Aug 24, 2010·0 cites·10 claims
- 2060US2008108652A1Imidazo (4,5-B) pyridine-derivatives as inducible no-synthase inhibitorsALTANA PHARMA AG·Filed 2007·Application pending·0 cites
- 2159US12344604B2Imidazolonylquinoline compounds and therapeutic uses thereofMERCK PATENT GMBH·Filed 2020·Granted Jul 1, 2025·0 cites·8 claims
- 2257US2023301991A1Compounds for the treatment of viral infectionsMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 2355US2023226066A1Compounds for the treatment of viral infectionsMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 2453US8492440B2Difluorophenyldiacylhydrazide derivativesFUCHSS THOMAS·Filed 2009·Granted Jul 23, 2013·0 cites·12 claims
- 2553US7329677B2Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitorsALTANA PHARMA AG·Filed 2004·Granted Feb 12, 2008·0 cites·6 claims
- 2651US6812349B2Process and intermediates for the preparation of imidazopyridinesALTANA PHARMA AG·Filed 2003·Granted Nov 2, 2004·0 cites·4 claims
- 2750US2023271956A1Amide derivativesMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 2850US2017166567A1Imidazo[4,5-c]quinolines as dna-pk inhibitorsMERCK PATENT GES MIT BESCHRANKTER HAFTUNG·Filed 2017·Application pending·0 cites
- 2950US2024009175A9Tetrazole derivativesMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 3048US2010280002A1Aminopyridine-derivatives as inductible no-synthase inhibitorsALTANA PHARMA AG·Filed 2010·Application pending·0 cites
- 3147US7790710B2Imidazopyridine derivatives useful as iNOS inhibitorsNYCOMED GMBH·Filed 2006·Granted Sep 7, 2010·0 cites·10 claims
- 3245US9718785B21,3-Disubstituted cyclopentane derivativesMERCK PATENT GMBH·Filed 2014·Granted Aug 1, 2017·0 cites·13 claims
- 3342US9187469B2Morpholinylbenzotriazines for use in cancer therapyMERCK PATENT GMBH·Filed 2012·Granted Nov 17, 2015·0 cites·9 claims
- 3438US8802712B2PyrazoloquinolinesFUCHSS THOMAS·Filed 2011·Granted Aug 12, 2014·0 cites·18 claims
- 3537US2010317650A1Imidazopyridine derivatives useful as inos inhibitorsNYCOMED GMBH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Fuchss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →